Xiangshaliujunzi Decoction for the treatment of diabetic gastroparesis: A systematic review

World Journal of Gastroenterology

Volumn 20, Issue 2, 2014, Pages 561-568

  Tian, Jia Xing ^a,b   Li, Min ^a   Liao, Jiang Quan ^b   Liu, Wen Ke ^a   Tong, Xiao Lin ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Diabetic gastroparesis; Gastric emptying rate; Gastrointestinal symptoms; Systematic review; Xiangshaliujunzi Decoction

Indexed keywords

GASTROINTESTINAL AGENT; HERBACEOUS AGENT; XIANGSHALIUJUNZI DECOCTION;

DIABETES COMPLICATIONS; DRUG EFFECTS; EVIDENCE BASED MEDICINE; GASTROPARESIS; HUMAN; MEDICINAL PLANT; META ANALYSIS; PATHOPHYSIOLOGY; PHYTOTHERAPY; STOMACH EMPTYING; TREATMENT OUTCOME;

DIABETES COMPLICATIONS; DRUGS, CHINESE HERBAL; EVIDENCE-BASED MEDICINE; GASTRIC EMPTYING; GASTROINTESTINAL AGENTS; GASTROPARESIS; HUMANS; PHYTOTHERAPY; PLANTS, MEDICINAL; TREATMENT OUTCOME;

EID: 84892896394     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i2.561     Document Type: Article

References (43)

1. Parkman HP, Camilleri M, Farrugia G, McCallum RW, Bharucha AE, Mayer EA, Tack JF, Spiller R, Horowitz M, Vinik AI, Galligan JJ, Pasricha PJ, Kuo B, Szarka LA, Marciani L, Jones K, Parrish CR, Sandroni P, Abell T, Ordog T, Hasler W, Koch KL, Sanders K, Norton NJ, Hamilton F. Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil 2010; 22: 113-133 [PMID: 20003077 DOI: 10.1111/j.1365-2982.2009.01434.x]
2. Thazhath SS, Jones KL, Horowitz M, Rayner CK. Diabetic gastroparesis: recent insights into pathophysiology and implications for management. Expert Rev Gastroenterol Hepatol 2013; 7: 127-139 [PMID: 23363262 DOI: 10.1586/egh.12.82]
3. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med 2001; 161: 1989-1996 [PMID: 11525701]
4. Camilleri M, Bharucha AE, Farrugia G. Epidemiology, mechanisms, and management of diabetic gastroparesis. Clin Gastroenterol Hepatol 2011; 9: 5-12; quiz e7 [PMID: 20951838 DOI: 10.1016/j.cgh.2010.09.022]
5. Khoo J, Rayner CK, Jones KL, Horowitz M. Pathophysiology and management of gastroparesis. Expert Rev Gastroenterol Hepatol 2009; 3: 167-181 [PMID: 19351287 DOI: 10.1586/ egh.09.10]
6. Abell TL, Bernstein RK, Cutts T, Farrugia G, Forster J, Hasler WL, McCallum RW, Olden KW, Parkman HP, Parrish CR, Pasricha PJ, Prather CM, Soffer EE, Twillman R, Vinik AI. Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil 2006; 18: 263-283 [PMID: 16553582]
7. Aljarallah BM. Management of diabetic gastroparesis. Saudi J Gastroenterol 2011; 17: 97-104 [PMID: 21372345 DOI: 10.4103/1319-3767.77237]
8. Kashyap P, Farrugia G. Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years. Gut 2010; 59: 1716-1726 [PMID: 20871131 DOI: 10.1136/gut.2009.199703]
9. Pasricha PJ, Pehlivanov N, Sugumar A, Jankovic J. Drug Insight: from disturbed motility to disordered movement--a review of the clinical benefits and medicolegal risks of metoclopramide. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 138-148 [PMID: 16511548]
10. Arts J, Holvoet L, Caenepeel P, Bisschops R, Sifrim D, Verbeke K, Janssens J, Tack J. Clinical trial: a randomizedcontrolled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther 2007; 26: 1251-1258 [PMID: 17944739]
11. Friedenberg FK, Palit A, Parkman HP, Hanlon A, Nelson DB. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol 2008; 103: 416-423 [PMID: 18070232]
12. Malagelada JR, Distrutti E. Management of gastrointestinal motility disorders. A practical guide to drug selection and appropriate ancillary measures. Drugs 1996; 52: 494-506 [PMID: 8891462]
13. Punkkinen J, Färkkilä M, Mätzke S, Korppi-Tommola T, Sane T, Piirilä P, Koskenpato J. Upper abdominal symptoms in patients with Type 1 diabetes: unrelated to impairment in gastric emptying caused by autonomic neuropathy. Diabet Med 2008; 25: 570-577 [PMID: 18445170 DOI: 10.1111/ j.1464-5491.2008.02428.x]
14. Wang YR, Fisher RS, Parkman HP. Gastroparesis-related hospitalizations in the United States: trends, characteristics, and outcomes, 1995-2004. Am J Gastroenterol 2008; 103: 313-322 [PMID: 18047541]
15. Bi JH, Yang TR. The experimental research of xiangshaliujunzi tang and its separated formulae on pepsin, SOD and MDA content of spleen deficiency gastric ulcer model rats. Nanjing Zhongyiyao Daxue Xuebao 2010; 26: 280-282 [DOI: 10.3969/j.issn.1000-5005.2010.04.013]
16. Wen YH, Liang S, Liang ZS, Zhang ZR, Zheng Q, Yang HL. The effect of Xiangshaliujunzi Decoction to acute gastric mucosal injury. Guangdong Yixue 2007; 28: 30-32 [DOI: 10.3969/ j.issn.1001-9448.2007.01.013]
17. Wang J, Huang SP, Zhao XQ, Chen Y. Gastric hypersensitivity and the variation of Mucosa substance P, 5-HT in functional dyspepsia. Xinzhongyi 2012; 44: 42-44
18. Chen J, Li ZZ, Miao WH, Yang CG. Xiangshaliujunzi decoction treating 60 gastric cancer patients in Qi deficiency. Shaanxi Zhongyi Xueyuan Xuebao 2006; 27: 1231-1232[DOI: 10.3969/j.issn.1000-7369.2006.10.049]
19. Gao Y. Moderated Xiangshaliujunzi decoction treating Helicobacter pylori-associated gastritis. Shizhen Guoyi Guoyao 2011; 22: 1283-1284 [DOI: 10.3969/j.issn.1008-0805.2011.05.116]
20. Pan ZL, Pan XG, Pan XD. The Clinical application of Xiang-shaliujunzi Decoction in stomach illness. Zhongyi Zazhi 2009; 50: 65
21. Yi PY, Zhu FS. Traditional Chinese Medicine therapy and decoction application in chronic atrophic gastritis. Shijie Huaren Xiaohua Zazhi 2011; 19: 3696-3699
22. Zhang ZH. The Pharmacology and clinical application of Xiangshaliujunzi decoction. Liaoning Zhongyiyao Daxue Xuebao 2013; 15: 245-247
23. Kang LN, Lin XL. The Pharmacology and clinical application of Xiangshaliujunzi decoction in resent 10 years. Jiangxi Zhongyi Xueyuan Xuebao 2010; 41: 67-69 [DOI: 10.3969/j.issn. 0411-9584.2010.10.037]
24. Zhang XP, Sun SJ. The effect of moderated Liujunzi decoction to plasma motilin in functional dyspepsia. Zhongyi Zazhi 2002; 43: 517-519
25. Liu K, Qi QH. Conduction disturbances of gastric motilin in spleen-qi deficiency syndrome. Zhongguo Zhongxiyi Jiehe Waike Zazhi 2004; 10: 300-302 [DOI: 10.3969/j.issn.1007-6948. 2004.04.024]
26. Chen FJ, Qian JH. The impact of Integrative Medicine to gastric motilin in critically ill patients with gastrointestinal dysfunction. Zhongguo Zhongyi Jizheng 2009; 18: 505-506
27. Li J, Liu B, Li FY. The impact of Xiangshaliujunzi decoction to the animal model of spleen deficient gastric uler rat. Liaoning Zhongyiyao Daxue Xuebao 2008; 35: 34-35 [DOI: 10.3969/ j.issn.1000-1719.2008.04.015]
28. Wang WP. Xiangshaliujunzi decoction treating Diabetic gastroparesis. Jiceng Yixue Luntan 2004; 8: 144-145 [DOI: 10.3969/j.issn.1672-1721.2004.02.035]
29. Ye JQ. Xiangshaliujunzi decoction combined with Banxiaxiexin decoction treating Diabetic gastroparesis. Neimenggu Zhongyiyao 2012; (16): 13
30. Higgins JPT. Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. 0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from: URL: http://www. cochrane-handbook. org
31. Cai D. Xiangshaliujunzi decoction treating Diabetic gastroparesis. (Master Thesis) Hubei University of Chinese Medicine, Wuhan, China, 2011
32. Feng ML. Moderated Xiangshaliujunzi decoction treating 64 Diabetic gastroparesis patients. Zhongguo Zhongyiyao Xinxi Zazhi 2010; 2: 59
33. Guo QH, Zhai LL. Moderated Xiangshaliujunzi decoction treating 32 Diabetic gastroparesis patients. Yunnan Zhongyi Zhongyao Zazhi 2009; 30: 31 [DOI: 10.3969/j.issn.1007-2349.20 09.06.025]
34. Lu YW. Moderated Xiangshaliujunzi decoction treating Diabetic gastroparesis. Liaoning Zhongyiyao Daxue Xuebao 2009; 11: 136-137
35. Lu YC, Yu XL. Xiangshaliujunzi decoction combined with Xuanfudaizhe decoction treating 72 Diabetic gastroparesis patients. Jiangsu Zhongyiyao 2011; 43: 42-43 [DOI: 10.3969/ j.issn.1672-397X.2011.02.026]
36. Meng YF. Moderated Xiangshaliujunzi decoction treating 32 Diabetic gastroparesis patients. Zhongwai Jiankang Wenzhai 2012; 9: 414
37. Wen ZQ. Moderated Xiangshaliujunzi decoction treating 44 Diabetic gastroparesis patients. Zhongguo Linchuang Yanjiu 2012; 25: 608-609
38. Dai BH. Moderated Xiangshaliujunzi decoction treating 36. Diabetic gastroparesis patients. Hebei Zhongyi 2003; 25: 809-810 [DOI: 10.3969/j.issn.1002-2619.2003.11.003]
39. Ji ML. Moderated Xiangshaliujunzi decoction treating Diabetic gastroparesis. Shanxi Yiyao Zazhi 2009; 38: 622[DOI: 10.3969/j.issn.0253-9926-B.2009.07.038]
40. Hou JZ, Zhang Q, Yan GH. Moderated Xiangshaliujunzi decoction treating 56 Diabetic gastroparesis patients. Xinzhongyi 2010; 42: 17-19
41. Tong XL. Interpretation of Traditional Chinese medicine prevention guide for diabetes. China: Chinese Medicine Press, 2009: 166-167
42. Jones KL, Russo A, Berry MK, Stevens JE, Wishart JM, Horowitz M. A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus. Am J Med 2002; 113: 449-455 [PMID: 12427492]
43. Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, Tack J. Development and validation of a patientassessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther 2003; 18: 141-150 [PMID: 12848636]